(Q37914880)

25 August 2017

1 reference

title

Solid lipid nanoparticles: an oral bioavailability enhancer vehicle (English)

1 reference

25 August 2017

0 references

1 reference

3

1 reference

25 August 2017

Harshad Harde

1

1 reference

25 August 2017

Manasmita Das

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

11 August 2011

1 reference

Expert Opinion on Drug Delivery

25 August 2017

published in

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1407-1424

1 reference

The impact of nanobiotechnology on the development of new drug delivery systems.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Solid lipid nanoparticles: production, characterization and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Body distribution of camptothecin solid lipid nanoparticles after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Solid lipid nanoparticles for parenteral drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Lipid nanomedicines for anticancer drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Oral solid lipid nanoparticle-based antitubercular chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Issues in oral nanoparticle drug carrier uptake and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Gastrointestinal uptake of biodegradable microparticles: effect of particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Comparison of wax and glyceride solid lipid nanoparticles (SLN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Stability of lipid excipients in solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Temperature scanning ultrasonic velocity study of complex thermal transformations in solid lipid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

The size of solid lipid nanoparticles: an interpretation from experimental design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Solid lipid nanoparticles as drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Influence of the formulation for solid lipid nanoparticles prepared with a membrane contactor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

Design and production of nanoparticles formulated from nano-emulsion templates-a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.604311

10.1517/17425247.2011.604311

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference